Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML

NCT02073838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Ribavirin
DRUG: Vismodegib
DRUG: Decitabine

Sponsor

Sarit Assouline